Skincare Anarchy LLC

Your skincare shouldn’t stop at your jawline.

In this episode, Dr. Jacquiline Hakim explains why the face and neck should be treated as one cosmetic unit. Because the neck naturally has fewer sebaceous glands, it may require a little more care—but consistent skincare, sun protection, and treatments like XERF can help support collagen and skin quality across both areas.

🎧 Listen to the full episode with Dr. Hakim to learn more about skin tightening, prevention, and the science behind XERF.

Precision Skin Tightening: Understanding XERF with Dr. Jacquiline Hakim - E. 876

In this episode of Skin Anarchy, Dr. Ekta Yadav sits down with Dr. Jacquiline Hakim, double board-certified dermatologist and cosmetic specialist, to explore what aging actually looks like beneath the surface. Rather than treating wrinkles, laxity, or volume loss as isolated concerns, Hakim explains how bone, fat, connective tissue, collagen, elastin, hormones, and skin are all changing simultaneously—and why understanding those layers is essential to creating natural aesthetic outcomes. 

The conversation explores the increasingly popular concept of “collagen banking” and what it means to support the body’s ability to produce collagen before significant loss occurs. Hakim also discusses why injectables and energy-based treatments shouldn’t be positioned as competing categories: the right intervention depends on what is actually happening anatomically in each patient. Her philosophy is simple—great aesthetic work shouldn’t announce itself. 

A major focus of the episode is radiofrequency and the evolution of skin-tightening technology. Hakim explains how controlled thermal energy can stimulate collagen and elastin production, why depth and precision matter, and how newer technologies such as XERF combine targeted energy delivery with epidermal cooling. The discussion also addresses treating skin of color and why device selection and provider expertise are critical when minimizing the risk of unwanted pigmentary changes. 

Hakim also challenges the growing trend of treatment stacking, emphasizing that more procedures don’t necessarily create better results. Sometimes tightening first can change whether filler is needed at all. 

Listen to the full episode to hear Jacquiline Hakim discuss collagen banking, radiofrequency, injectables, skin tightening, regenerative aesthetics, and why the future of aesthetic medicine may be less about changing how we look—and more about helping us continue to look like ourselves.

Retinoids may be powerful—but they’re only one piece of the skin biology puzzle.

Drawing on decades of clinical experience and research, Dr. Carl Thornfeldt explores tretinoin’s effects on epidermal turnover, barrier function, photosensitivity, and why long-term skin health requires looking beyond a single pathway or ingredient.

The bigger conversation? Effective skincare requires understanding the entire biological system—not simply maximizing one active.

🎧 Listen to the full episode with Dr. Thornfeldt for a deeper discussion on retinoids, barrier biology, and evidence-based skin health.

Understanding Barrier Repair with Dr. Carl Thornfeldt of Epionce - E. 875

In this episode of Skin Anarchy, Dr. Ekta Yadav sits down with Dr. Carl Thornfeldt, founder of Epionce, to explore the science of skin barrier health decades before “barrier repair” became one of beauty’s biggest trends. Drawing from years of dermatologic research and his own childhood experience with atopic dermatitis, Dr. Thornfeldt explains why healthy skin begins not with chasing individual symptoms, but with understanding how the epidermis is designed to function and repair itself. 

At the center of the conversation is a more nuanced understanding of barrier repair. Dr. Thornfeldt explains why ceramides alone don’t tell the full story—and how cholesterol, ceramides, and free fatty acids must work together in appropriate relationships to support barrier architecture. He also distinguishes between simply moisturizing the skin and actually helping restore the biological processes responsible for barrier function. 

The discussion also challenges some of skincare’s most persistent assumptions. Higher percentages aren’t automatically more effective, a promising ingredient mechanism doesn’t guarantee a successful product, and emerging technologies like exosomes still need to prove that they remain stable, reach their intended targets, and produce meaningful results in humans.
For Dr. Thornfeldt, the finished formulation—not an ingredient story—is ultimately what needs to demonstrate efficacy. 
That philosophy became the foundation of Epionce: begin with skin biology, formulate around the mechanisms that influence healthy function, and then clinically study the products consumers actually use.

Listen to the full episode to hear Dr. Carl Thornfeldt discuss the research behind modern barrier science, the development of Epionce, and why the future of skincare should be driven by physiology and evidence—not whichever ingredient happens to be trending next. 

Exosomes aren’t the message—they’re the delivery system. 🧬

In this episode, Dr. Drew Taylor of Acorn Biolabs explains how stem cells communicate with surrounding cells through signaling molecules, including those packaged inside exosomes. Think of an exosome like an Amazon Prime package: what matters isn’t simply the box, but what’s actually being delivered.

Understanding that distinction is critical as exosomes become an increasingly prominent part of regenerative medicine, hair science, and aesthetics.

🎧 Listen to the full episode with Dr. Drew Taylor to explore the science behind stem cells, cellular signaling, and the future of regenerative medicine.

The Secretome: The Next Frontier in Regenerative Medicine with Dr. Drew Taylor of Acorn Biolabs - E. 874

In this episode of Skin Anarchy, Dr. Ekta Yadav sits down with Dr. Drew Taylor, CEO of Acorn Biolabs, to unpack one of the most exciting—and misunderstood—frontiers in regenerative aesthetics: the secretome. As exosomes, stem cells, growth factors, peptides, and PDRN increasingly enter the beauty conversation, Dr. Taylor explains why understanding how cells actually communicate may be far more important than chasing the latest regenerative buzzword. 

At the center of the conversation is an important distinction: exosomes are the package, not the message. Their biological value ultimately depends on the cargo they carry. Dr. Taylor expands the discussion to the secretome—the broader network of exosomes, growth factors, cytokines, proteins, peptides, extracellular matrix molecules, and other signals cells use to influence repair and regeneration. Rather than isolating one molecule, the secretome offers a window into the complex biological “orchestra” happening between cells. 

The episode also challenges some of regenerative aesthetics’ biggest marketing claims. Does a younger donor automatically mean better biology? Does a trillion exosomes guarantee greater efficacy? Dr. Taylor explains why cell expansion, passage number, biological cargo, and functional activity may matter far more than impressive particle counts or donor age alone. 

Dr. Taylor also explores Acorn’s autologous approach—preserving an individual’s own cells for potential future applications—and why cell banking could become increasingly relevant as regenerative medicine advances across skin, hair, orthopedics, and beyond. 

Listen to the full episode to hear Dr. Drew Taylor break down secretomes, exosomes, autologous cell banking, and why the future of regenerative aesthetics may depend less on bigger claims and more on understanding what our own biology is actually capable of.

What do people really want from their skin?

On the podcast, Joanna Vargas reflects on a surprising pattern she noticed early in her career: across ages and stages of life, clients consistently wanted the same thing—clean, clear, glowing skin.

That realization helped shape a philosophy centered less on making people feel like something needs to be “fixed” and more on helping them feel confident in the skin they already have.

🎧 Listen to the full episode with Joanna Vargas to hear more about her nearly three decades of working with skin and the philosophy behind her approach.

Joanna Vargas on the Science and Art of Great Skin - E. 873

In this episode of Skin Anarchy, Dr. Ekta Yadav sits down with celebrity esthetician and skincare founder Joanna Vargas to unpack nearly three decades of lessons from working directly with skin. In an industry overflowing with new ingredients, devices, and increasingly complicated routines, Joanna offers a refreshingly simple perspective: great skin isn’t about doing everything—it’s about understanding what your skin actually needs. 

Joanna reflects on how her early curiosity led her to become an early adopter of technologies like LED and microcurrent, long before they became fixtures of modern aesthetics. Rather than separating natural skincare from clinical innovation, she built a philosophy around thoughtfully combining both—and evaluating every new technology by what she actually saw happening on her clients’ skin. 

The conversation also challenges some of skincare’s most persistent extremes. Exfoliation isn’t inherently damaging; over-exfoliation is. New ingredients aren’t automatically better than established ones. And an elaborate routine isn’t necessarily more effective than a cleanser, targeted serum, and moisturizer someone will consistently use. After watching countless trends come and go, Joanna explains why proven ingredients, personalization, and restraint often outperform novelty. 

Beyond products, Joanna discusses the complementary roles of dermatologists and estheticians, what decades of high-profile clientele have taught her about building trust, and why neither skincare professionals nor beauty marketing should leave consumers feeling as though their faces need fixing. 
Listen to the full episode to hear Joanna Vargas discuss LED, microcurrent, exfoliation, emerging skincare science, and why the best routine may ultimately be much simpler than the beauty industry wants us to believe.

As medical aesthetics grows, the question isn’t just how big can the industry get?—it’s how well can it scale.

On the podcast, Dominic Mazzone discusses the rapid expansion of aesthetic clinics across the U.S. and Canada and why maintaining provider expertise, clinical standards, and patient outcomes becomes increasingly important as the market grows.

He also highlights a critical question for emerging skincare brands: What lane are you actually in? Medical aesthetics and traditional beauty retail require very different strategies, standards, and approaches to building credibility.

🎧 Listen to the full episode with Dominic to explore the evolving business of medical aesthetics and what it takes to succeed in the professional skincare channel.

What Separates Medical Aesthetics from Retail Aesthetics with Dominic Mazzone of VOS Collection - E. 872

In this episode of Skin Anarchy, Dr. Ekta Yadav sits down with Dominic Mazzone, CEO of VOS Collection, to explore the business infrastructure behind modern medical aesthetics—and why the industry’s next phase may be defined less by rapid expansion and more by clinical excellence. As aesthetic practices continue to multiply, Dominic examines what separates a truly exceptional medical practice from one built primarily around volume. 
At the center of the conversation is a philosophy that challenges traditional approaches to scaling medicine: build infrastructure around great clinicians, not over them. Dominic explains why protecting physician autonomy, investing in education, and prioritizing remarkable patient outcomes can create stronger businesses without allowing financial incentives to dictate clinical decisions. In fact, he argues that better medicine and better business may be more closely connected than the industry realizes. 

The discussion also explores the emerging divide between “medical aesthetics” and “retail aesthetics.” As treatments become increasingly accessible, consumers need to understand that not every clinic offers the same depth of expertise, comprehensive treatment planning, technology, or clinical oversight. Dominic shares what VOS looks for when evaluating practices and why culture, ethics, patient experience, and continued learning matter alongside technical skill. 

For skincare founders, the episode offers another important perspective: clinical efficacy alone isn’t enough to build a successful medical-grade brand. Education, provider confidence, consumer demand, distribution, and staff training all determine whether a great formula ever becomes meaningful inside a practice. 

Listen to the full episode to hear Dominic Mazzone discuss the evolution of medical aesthetics, scaling physician-led practices, mentorship, medical-grade skincare, and why better patient outcomes may ultimately be the industry’s most powerful growth strategy.